Dendritic cells resurrect antigens from dead cells

Bevan, 1976, Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay, J. Exp. Med., 143, 1283, 10.1084/jem.143.5.1283 Gordon, 1975, In vitro cell-mediated immune responses to the male specific (H-Y) antigen in mice, J. Exp. Med., 142, 1108, 10.1084/jem.142.5.1108 Gooding, 1980, H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes, J. Immunol., 124, 1258, 10.4049/jimmunol.124.3.1258 Huang, 1994, Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens, Science, 264, 961, 10.1126/science.7513904 Kurts, 1996, Constitutive class I-restricted exogenous presentation of self antigens in vivo, J. Exp. Med., 184, 923, 10.1084/jem.184.3.923 Lenz, 2000, Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens, J. Exp. Med., 192, 1135, 10.1084/jem.192.8.1135 Sigal, 1999, Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen, Nature, 398, 77, 10.1038/18038 Sigal, 2000, Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation, J. Exp. Med., 192, 1143, 10.1084/jem.192.8.1143 Kurts, 1997, Class I-restricted cross-presentation of exogenous self antigens leads to deletion of autoreactive CD8+ T cells, J. Exp. Med., 186, 239, 10.1084/jem.186.2.239 Yewdell, 1999, Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T-cell responses to infectious agents, tumors, transplants, and vaccines, Adv. Immunol., 73, 1, 10.1016/S0065-2776(08)60785-3 Huang, 1996, In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter, Immunity, 4, 349, 10.1016/S1074-7613(00)80248-4 Bennett, 1997, Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help, J. Exp. Med., 186, 65, 10.1084/jem.186.1.65 Schoenberger, 1998, T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions, Nature, 393, 480, 10.1038/31002 Green, 2000, Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells, J. Exp. Med., 191, 225, 10.1084/jem.191.2.225 Lu, 2000, CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes, J. Exp. Med., 191, 541, 10.1084/jem.191.3.541 Larsson, 2000, Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells, J. Immunol., 165, 1182, 10.4049/jimmunol.165.3.1182 Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588 Steinman, 1999, Dendritic cells, 547 Dhodapkar, 2000, Active immunization of humans with dendritic cells, J. Clin. Immunol., 20, 167, 10.1023/A:1006681312249 Albert, 1998, Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs, Nature, 392, 86, 10.1038/32183 Yrlid, 2000, Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells, J. Exp. Med, 191, 613, 10.1084/jem.191.4.613 Mitchell D.A. et al. (1998) Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells [published erratum appears in Eur. J. Immunol. (1998) 28, 3891]. Eur. J. Immunol. 28, 1923–1933 Rodriguez, 1999, Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells, Nat. Cell Biol., 1, 362, 10.1038/14058 Ronchetti, 1999, Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines, J. Immunol., 163, 130, 10.4049/jimmunol.163.1.130 Inaba, 1998, Efficient presentation of phagocytosed cellular fragments on the MHC class II products of dendritic cells, J. Exp. Med., 188, 2163, 10.1084/jem.188.11.2163 den Haan, 2000, CD8+ but not CD8− dendritic cells cross-prime cytotoxic T cells in vivo, J. Exp. Med., 192, 1685, 10.1084/jem.192.12.1685 Bellone, 1997, Processing of engulfed apoptotic bodies yields T cell epitopes, J. Immunol., 159, 5391, 10.4049/jimmunol.159.11.5391 Ke, 1996, Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediator uptake, J. Exp. Med., 184, 1179, 10.1084/jem.184.3.1179 Kovacsovics-Bankowski, 1993, Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages, Proc. Natl. Acad. Sci. USA, 90, 4942, 10.1073/pnas.90.11.4942 Norbury, 1995, Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages, Immunity, 3, 783, 10.1016/1074-7613(95)90067-5 Suto, 1995, A mechanism for the specific immunogenicity of heat shock-chaperoned peptides, Science, 269, 1585, 10.1126/science.7545313 Fadok, 1998, Macrophages that have ingested apoptosis cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2 and PAF, J. Clin. Invest., 101, 890, 10.1172/JCI1112 Lopes, 2000, The macrophage haunted by cell ghosts: a pathogen grows, Immunol. Today, 21, 489, 10.1016/S0167-5699(00)01713-8 Herr, 2000, Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses, Blood, 96, 1857, 10.1182/blood.V96.5.1857 Srivastava, 1998, Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world, Immunity, 8, 657, 10.1016/S1074-7613(00)80570-1 Zitvogel, 1998, Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes, Nat. Med., 4, 594, 10.1038/nm0598-594 Regnault, 1999, Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization, J. Exp. Med., 189, 371, 10.1084/jem.189.2.371 Huang, 2000, A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes, J. Exp. Med., 191, 435, 10.1084/jem.191.3.435 Jenne, 2000, Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis, Cancer Res., 60, 4446 Plautz, 2000, Cross-presentation of tumor antigens to effector T cells is sufficient to mediate effective immunotherapy of established intracranial tumors, J. Immunol., 165, 3656, 10.4049/jimmunol.165.7.3656 Sauter, 2000, Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells, J. Exp. Med., 191, 423, 10.1084/jem.191.3.423 Gallucci, 1999, Natural adjuvants: endogenous activators of dendritic cells, Nat. Med., 5, 1249, 10.1038/15200 Rovere, 1998, Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function, J. Immunol., 161, 4467, 10.4049/jimmunol.161.9.4467 Ignatius, 2000, Canarypox-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor-α secretion, J. Virol., 74, 11329, 10.1128/JVI.74.23.11329-11338.2000 Salio, 1999, Inhibition of dendritic cell maturation by herpes simplex virus, Eur. J. Immunol., 29, 3245, 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.0.CO;2-X Binder, 2000, CD91: a receptor got heat shock protein gp96, Nat. Immunol., 1, 151, 10.1038/77835 Todryk, 1999, Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake, J. Immunol., 163, 1398, 10.4049/jimmunol.163.3.1398 Basu, 2000, Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappaB pathway, Int. Immunol., 12, 1539, 10.1093/intimm/12.11.1539 Albert, 1998, Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes, J. Exp. Med., 188, 1359, 10.1084/jem.188.7.1359 Albert, 2000, αvβ5 integrin recruits the CrkII–Dock180–Rac1 complex for phagocytosis of apoptotic cells, Nat. Cell Biol., 2, 899, 10.1038/35046549 von Boehmer, 1984, Thymocytes appear to ignore class I major histocompatibility complex antigens expressed on the thymus epithelial cells, Eur. J. Immunol., 14, 1048, 10.1002/eji.1830141116 Morgan, 1999, Antigen concentration and precursor frequency determine the rate of CD8+ T-cell tolerance to peripherally expressed antigens, J. Immunol., 163, 723, 10.4049/jimmunol.163.2.723 Kurts, 1998, Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction, J. Exp. Med., 188, 409, 10.1084/jem.188.2.409 Taylor, 2000, A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo, J. Exp. Med., 192, 359, 10.1084/jem.192.3.359 Munz, 2000, Human CD4(+) T lymphocytes consistently respond to the latent Epstein–Barr virus nuclear antigen EBNA1, J. Exp. Med., 191, 1649, 10.1084/jem.191.10.1649 Albert, 1998, Tumor-specific and anti-neuronal killer cells in paraneoplastic cerebellar degeneration, Nat. Med., 4, 1321, 10.1038/3315 Hoffmann, 2000, Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells, Cancer Res., 60, 3542 Russo, 2000, Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T-cell response, Proc. Natl. Acad. Sci. USA, 97, 2185, 10.1073/pnas.040540197 Kronin, 1996, A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production, J. Immunol., 157, 3819, 10.4049/jimmunol.157.9.3819 Jonuleit, 2000, Induction of human IL-10-producing, non-proliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature dendritic cells, J. Exp. Med., 192, 1213, 10.1084/jem.192.9.1213 Dhodopkar, M.V. et al. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. (in press) Restifo, 2000, Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity, Curr. Opin. Immunol., 12, 597, 10.1016/S0952-7915(00)00148-5 Bennett, 1998, Help for cytotoxic-T-cell responses is mediated by CD40 signalling, Nature, 393, 478, 10.1038/30996 Nestle, 1998, Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells, Nat. Med., 4, 328, 10.1038/nm0398-328 Thurner, 1999, Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma, J. Exp. Med., 190, 1669, 10.1084/jem.190.11.1669 Geiger, 2000, Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells, Lancet, 356, 1163, 10.1016/S0140-6736(00)02762-8